Aug 2026· Human Cell· Vol 39· 0 citations· 40 references
Medicine
TL;DR
These findings establish the first PDO and ODX models of ZFP64::NCOA3 fusion-positive SRMS and demonstrate fusion-gene dependency in this rare molecular subtype, and suggest that despite strong myogenic transcriptional programs, fusion-positive SRMS retains adipogenic differentiation capacity.
Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft tissue sarcoma of presumed peripheral nerve sheath origin, for which effective systemic therapies remain limited. The biological mechanisms underlying its progression and therapeutic vulnerabilities are not fully understood, partly due to the...
Haruki Matsuoka, Keiichi Yoshida, Yukiko Matsuoka et al.· Human Cell· 0 citations
Fusion-negative rhabdomyosarcoma (FN-RMS) is a childhood muscle cancer where relapse and refractory disease lead to poor outcomes. Our group has recently shown that FN-RMS is a cancer stem cell (CSC) disease and that these CD44+/CD90+/EGFR+ cells likely contribute to therapy-resistance, yet the precise mechanisms gov...
S. Mathavarajah, Tiffany C. Y. Eng, Elisa J. Quantin et al.· Cancer Research· 0 citations
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Alveolar RMS (ARMS) has a poor prognosis and is driven by either t(2;13)(q35;q14) or t(1;13)(p36;q14) translocations resulting in the PAX3::FOXO1 (P3F) and PAX7::FOXO1 (P7F) fusion oncoproteins, respectively. Current in vivo model systems fail t...
Bradley T. Stevens, Yang E. Zhang, Matthew R. Garcia et al.· Cancer Research· 0 citations